Vybrique is an oral film formulation of sildenafil, a phosphodiesterate-5 inhibitor, designed to dissolve on the tongue without the need for food or water.

Investigational antiviral pritelivir demonstrates efficacy and improved tolerability over current treatments for refractory HSV in high-risk patients.

HealthDay News — In a guideline issued by the American Heart Association/American Stroke Association and published online January 26 in Stroke, updated recommendations are presented for the early ...

Age-standardized prevalence varied by race and ethnicity group and by sex in 2022, with highest prevalence in non-Hispanic Black women.

HealthDay News — For women who are vaccinated against human papillomavirus (HPV) by age 30 years, a high-value screening program likely involves less frequent screening, according to a study published ...

HealthDay News — In a consensus statement published online February 2 in JAMA Network Open, the appropriateness of empiric antibiotics, urine testing, and clinical evaluation options are considered ...

FreeStyle Libre 3 and 3 Plus are continuous glucose monitoring devices indicated for the management of diabetes in patients aged 4 years and older.

Sonelokimab receives FDA Fast Track status for palmoplantar pustulosis following phase 2 trial data showing significant symptom reduction.

Additional benefits seen for diastolic blood pressure and concentrations of triglycerides and aspartate aminotransferase.

Of 38 paused databases on October 28, 2025, 33 were vaccination-related topics; only one was updated as of December 2, 2025 ...

Seventy-one percent of patients had pathological complete response; 7% experienced grade 3 treatment-related adverse events.

HealthDay News — A fast-growing measles outbreak in South Carolina has eclipsed last year’s record-setting Texas surge. As of ...